These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 39731)

  • 21. Hyperreactivity to bee stings: reevaluation.
    Neuman I; Ishay JS; Creter D
    Ann Allergy; 1983 Jun; 50(6):410-2. PubMed ID: 6552888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyposensitization in wasp venom and bee venom allergy].
    Forck G
    Med Monatsschr Pharm; 1985 Apr; 8(4):107-12. PubMed ID: 4000054
    [No Abstract]   [Full Text] [Related]  

  • 23. Answer to the letter of Brockow et al. concerning our article 'safety of rush insect venom immunotherapy. Results of a retrospective study in 178 patients'.
    Wenzel J; Meissner-Kraemer M; Bauer R; Bieber T; Gerdsen R
    Allergy; 2005 Jan; 60(1):127. PubMed ID: 15575945
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyposensitization in allergy to insect stings: whole body extracts or venom? (author's transl)].
    Müller U; Patrizzi R; Thurnheer U; Hoigné R
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1978; 73():72-81. PubMed ID: 756214
    [No Abstract]   [Full Text] [Related]  

  • 25. [Basophil degranulation test (BDT) as a parameter of hyposensitization with Hymenoptera venoms].
    Dietschi R; Wüthrich B; Marti-Wyss S; Cuhat J
    Schweiz Med Wochenschr; 1987 Oct; 117(44):1728-35. PubMed ID: 3685930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 27. Ultrarush immunotherapy in a patient with occupational allergy to bumblebee venom (Bombus terrestris).
    Roll A; Schmid-Grendelmeier P
    J Investig Allergol Clin Immunol; 2005; 15(4):305-7. PubMed ID: 16433215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is desensitization always indicated in allergy to insect venoms?].
    Prybilla B; Ruëff F
    Dtsch Med Wochenschr; 1994 Aug; 119(31-32):1093-5. PubMed ID: 8055747
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract.
    Müller U; Thurnheer U; Patrizzi R; Spiess J; Hoigné R
    Allergy; 1979 Dec; 34(6):369-78. PubMed ID: 546252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of the basophil degranulation test (BDT) in the follow-up of immunotherapy with hymenoptera venoms].
    Wüthrich B; Dietschi R; Marti-Wyss S; Cuhat J
    Z Hautkr; 1987 Apr; 62(7):537-44. PubMed ID: 3590918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allergy to insect stings (author's transl)].
    Urbanek R; Karitzky D
    Klin Padiatr; 1977 Nov; 189(6):467-71. PubMed ID: 563944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bee venom immunotherapy.
    Oswald H
    Inforum; 1990; 11():10-1. PubMed ID: 2210838
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunologic studies in allergic children].
    Urbanek R
    Fortschr Med; 1981 Sep; 99(34):1367-9. PubMed ID: 7286882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insect sting allergy--indication of desensitization and problems in evaluating the therapy].
    Wenz W
    Allerg Immunol (Leipz); 1990; 36(3):183-7. PubMed ID: 2256462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insect venom allergy. Removing the sting of killer bees!].
    Przybilla B
    MMW Fortschr Med; 2001 May; 143(20):41-4. PubMed ID: 11400609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy.
    Ruëff F; Bilò MB; Jutel M; Mosbech H; Müller U; Przybilla B;
    J Allergy Clin Immunol; 2009 Jan; 123(1):272-3; author reply 273. PubMed ID: 19130944
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyposensitization therapy: current status].
    Fiandor Román AM; Pascual Marcos C
    An Esp Pediatr; 1985 Apr; 22(5):345-8. PubMed ID: 2409854
    [No Abstract]   [Full Text] [Related]  

  • 38. [The key role of IgG4 subclass antibodies in the development of protection against allergic reactions to insect stings].
    Urbanek R; Dold S
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):536-40. PubMed ID: 3773921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venom immunotherapy.
    Houliston L; Brookes I; Mallon DF
    N Engl J Med; 2004 Nov; 351(20):2129-30; author reply 2129-30. PubMed ID: 15537914
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.